Aethlon Medical (AEMD) Competitors

$2.14 0.00 (0.00%)

Closing price 04:00 PM Eastern

Extended Trading

$2.18 +0.04 (+1.96%)

As of 07:56 PM Eastern

AEMD vs. HIND, SURG, QNRX, LFWD, and ALUR

Should you buy Aethlon Medical stock or one of its competitors? MarketBeat compares Aethlon Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aethlon Medical include Vyome (HIND), SurgePays (SURG), Quoin Pharmaceuticals (QNRX), Lifeward (LFWD), and Allurion Technologies (ALUR). These companies are all part of the "medical equipment" industry.

How does Aethlon Medical compare to Vyome?

Vyome (NASDAQ:HIND) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

22.1% of Vyome shares are held by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are held by institutional investors. 33.0% of Vyome shares are held by insiders. Comparatively, 0.7% of Aethlon Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Vyome has higher revenue and earnings than Aethlon Medical. Aethlon Medical is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vyome	$320K	42.12	-$10.26M	-$125.20	N/A
Aethlon Medical	N/A	N/A	-$13.39M	-$14.69	N/A

Vyome has a beta of 1.38, suggesting that its share price is 38% more volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.5, suggesting that its share price is 50% more volatile than the broader market.

Aethlon Medical has a net margin of 0.00% compared to Vyome's net margin of -270.58%. Vyome's return on equity of -203.92% beat Aethlon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vyome	-270.58%	-203.92%	-134.16%
Aethlon Medical	N/A	-219.39%	-164.33%

In the previous week, Vyome had 3 more articles in the media than Aethlon Medical. MarketBeat recorded 5 mentions for Vyome and 2 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 1.43 beat Vyome's score of 0.71 indicating that Aethlon Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Vyome	Positive
Aethlon Medical	Positive

Vyome currently has a consensus target price of $15.00, indicating a potential upside of 681.25%. Given Vyome's stronger consensus rating and higher probable upside, equities research analysts plainly believe Vyome is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

Vyome beats Aethlon Medical on 10 of the 14 factors compared between the two stocks.

How does Aethlon Medical compare to SurgePays?

SurgePays (NASDAQ:SURG) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings and risk.

In the previous week, SurgePays had 3 more articles in the media than Aethlon Medical. MarketBeat recorded 5 mentions for SurgePays and 2 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 1.43 beat SurgePays' score of 0.78 indicating that Aethlon Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
SurgePays	Positive
Aethlon Medical	Positive

Aethlon Medical has a net margin of 0.00% compared to SurgePays' net margin of -63.32%. Aethlon Medical's return on equity of -219.39% beat SurgePays' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SurgePays	-63.32%	-967.32%	-241.91%
Aethlon Medical	N/A	-219.39%	-164.33%

Aethlon Medical has lower revenue, but higher earnings than SurgePays. SurgePays is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SurgePays	$56.96M	0.25	-$36.07M	-$1.81	N/A
Aethlon Medical	N/A	N/A	-$13.39M	-$14.69	N/A

SurgePays currently has a consensus price target of $5.00, suggesting a potential upside of 773.67%. Given SurgePays' stronger consensus rating and higher possible upside, analysts clearly believe SurgePays is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SurgePays	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

SurgePays has a beta of 0.32, indicating that its share price is 68% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.5, indicating that its share price is 50% more volatile than the broader market.

6.9% of SurgePays shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 29.1% of SurgePays shares are owned by insiders. Comparatively, 0.7% of Aethlon Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

SurgePays beats Aethlon Medical on 8 of the 14 factors compared between the two stocks.

How does Aethlon Medical compare to Quoin Pharmaceuticals?

Aethlon Medical (NASDAQ:AEMD) and Quoin Pharmaceuticals (NASDAQ:QNRX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, valuation, analyst recommendations, dividends, earnings and profitability.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Quoin Pharmaceuticals is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$13.39M	-$14.69	N/A
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$29.56	N/A

In the previous week, Aethlon Medical and Aethlon Medical both had 2 articles in the media. Aethlon Medical's average media sentiment score of 1.43 beat Quoin Pharmaceuticals' score of 1.22 indicating that Aethlon Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Aethlon Medical	Positive
Quoin Pharmaceuticals	Positive

2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 8.6% of Quoin Pharmaceuticals shares are held by institutional investors. 0.7% of Aethlon Medical shares are held by company insiders. Comparatively, 13.5% of Quoin Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Aethlon Medical has a beta of 1.5, indicating that its share price is 50% more volatile than the broader market. Comparatively, Quoin Pharmaceuticals has a beta of 1.61, indicating that its share price is 61% more volatile than the broader market.

Aethlon Medical's return on equity of -219.39% beat Quoin Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-219.39%	-164.33%
Quoin Pharmaceuticals	N/A	-489.85%	-221.29%

Summary

Aethlon Medical beats Quoin Pharmaceuticals on 6 of the 9 factors compared between the two stocks.

How does Aethlon Medical compare to Lifeward?

Lifeward (NASDAQ:LFWD) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations.

Aethlon Medical has lower revenue, but higher earnings than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$22.03M	0.46	-$19.91M	-$18.49	N/A
Aethlon Medical	N/A	N/A	-$13.39M	-$14.69	N/A

Lifeward presently has a consensus price target of $10.00, suggesting a potential upside of 51.65%. Given Lifeward's stronger consensus rating and higher possible upside, equities research analysts plainly believe Lifeward is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Aethlon Medical has a net margin of 0.00% compared to Lifeward's net margin of -90.38%. Lifeward's return on equity of -145.55% beat Aethlon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-90.38%	-145.55%	-78.36%
Aethlon Medical	N/A	-219.39%	-164.33%

In the previous week, Lifeward had 3 more articles in the media than Aethlon Medical. MarketBeat recorded 5 mentions for Lifeward and 2 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 1.43 beat Lifeward's score of 0.47 indicating that Aethlon Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Lifeward	Neutral
Aethlon Medical	Positive

26.8% of Lifeward shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 1.5% of Lifeward shares are owned by company insiders. Comparatively, 0.7% of Aethlon Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Lifeward has a beta of 0.32, indicating that its share price is 68% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.5, indicating that its share price is 50% more volatile than the broader market.

Summary

Lifeward beats Aethlon Medical on 9 of the 14 factors compared between the two stocks.

How does Aethlon Medical compare to Allurion Technologies?

Allurion Technologies (NYSE:ALUR) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

Allurion Technologies has a beta of -0.18, suggesting that its share price is 118% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.5, suggesting that its share price is 50% more volatile than the broader market.

Allurion Technologies presently has a consensus price target of $3.00, indicating a potential upside of 197.03%. Given Allurion Technologies' stronger consensus rating and higher probable upside, equities analysts clearly believe Allurion Technologies is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allurion Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Allurion Technologies has higher revenue and earnings than Aethlon Medical. Aethlon Medical is trading at a lower price-to-earnings ratio than Allurion Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allurion Technologies	$17.21M	0.88	-$7.20M	-$10.56	N/A
Aethlon Medical	N/A	N/A	-$13.39M	-$14.69	N/A

21.4% of Allurion Technologies shares are held by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are held by institutional investors. 8.1% of Allurion Technologies shares are held by company insiders. Comparatively, 0.7% of Aethlon Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Allurion Technologies and Allurion Technologies both had 2 articles in the media. Aethlon Medical's average media sentiment score of 1.43 beat Allurion Technologies' score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Allurion Technologies	Neutral
Aethlon Medical	Positive

Aethlon Medical has a net margin of 0.00% compared to Allurion Technologies' net margin of -199.96%. Allurion Technologies' return on equity of 0.00% beat Aethlon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allurion Technologies	-199.96%	N/A	-77.13%
Aethlon Medical	N/A	-219.39%	-164.33%

Summary

Allurion Technologies beats Aethlon Medical on 10 of the 13 factors compared between the two stocks.

Get Aethlon Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AEMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AEMD vs. The Competition

Export

Metric	Aethlon Medical	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.36M	$51.71B	$6.29B	$12.40B
Dividend Yield	N/A	1.80%	2.79%	5.30%
P/E Ratio	N/A	22.65	20.89	25.59
Price / Sales	N/A	0.59	523.43	63.12
Price / Cash	N/A	22.92	42.94	55.34
Price / Book	0.08	2.45	9.86	6.70
Net Income	-$13.39M	$1.46B	$3.55B	$333.77M
7 Day Performance	-6.96%	2.87%	-0.33%	0.45%
1 Month Performance	-7.36%	17.45%	1.34%	4.06%
1 Year Performance	-93.39%	-9.44%	41.10%	36.24%

Aethlon Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AEMD Aethlon Medical	1.4343 of 5 stars	$2.14 flat	N/A	-93.5%	$3.36M	N/A	N/A	10	Positive News Short Interest Decrease Gap Up
HIND Vyome	2.9429 of 5 stars	$2.07 -1.0%	$15.00 +624.6%	N/A	$14.67M	$320K	N/A	50	News Coverage Earnings Report
SURG SurgePays	2.9225 of 5 stars	$0.55 -3.5%	$5.00 +816.9%	-82.2%	$14.20M	$56.96M	N/A	40	Upcoming Earnings
QNRX Quoin Pharmaceuticals	0.4396 of 5 stars	$6.31 -0.8%	N/A	-7.1%	$11.47M	N/A	N/A	4	Positive News Earnings Report
LFWD Lifeward	2.0755 of 5 stars	$7.00 -1.0%	$10.00 +42.9%	-61.1%	$10.81M	$22.03M	N/A	60	News Coverage Upcoming Earnings Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AEMD) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aethlon Medical (AEMD) Competitors

AEMD vs. HIND, SURG, QNRX, LFWD, and ALUR

How does Aethlon Medical compare to Vyome?

Summary

How does Aethlon Medical compare to SurgePays?

Summary

How does Aethlon Medical compare to Quoin Pharmaceuticals?

Summary

How does Aethlon Medical compare to Lifeward?

Summary

How does Aethlon Medical compare to Allurion Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AEMD vs. The Competition

Aethlon Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aethlon Medical (AEMD) Competitors

AEMD vs. HIND, SURG, QNRX, LFWD, and ALUR

How does Aethlon Medical compare to Vyome?

Do insiders & institutionals have more ownership in HIND or AEMD?

Which has preferable valuation & earnings, HIND or AEMD?

Which has more risk and volatility, HIND or AEMD?

Is HIND or AEMD more profitable?

Does the media favor HIND or AEMD?

Do analysts recommend HIND or AEMD?

Summary

How does Aethlon Medical compare to SurgePays?

Does the media favor SURG or AEMD?

Is SURG or AEMD more profitable?

Which has higher earnings & valuation, SURG or AEMD?

Do analysts recommend SURG or AEMD?

Which has more risk and volatility, SURG or AEMD?

Do institutionals and insiders hold more shares of SURG or AEMD?

Summary

How does Aethlon Medical compare to Quoin Pharmaceuticals?

Do analysts rate AEMD or QNRX?

Which has preferable earnings & valuation, AEMD or QNRX?

Does the media favor AEMD or QNRX?

Do insiders & institutionals have more ownership in AEMD or QNRX?

Which has more risk & volatility, AEMD or QNRX?

Is AEMD or QNRX more profitable?

Summary

How does Aethlon Medical compare to Lifeward?

Which has preferable valuation and earnings, LFWD or AEMD?

Do analysts prefer LFWD or AEMD?

Is LFWD or AEMD more profitable?

Does the media prefer LFWD or AEMD?

Do insiders & institutionals hold more shares of LFWD or AEMD?

Which has more volatility & risk, LFWD or AEMD?

Summary

How does Aethlon Medical compare to Allurion Technologies?

Which has more risk and volatility, ALUR or AEMD?

Do analysts prefer ALUR or AEMD?

Which has better valuation and earnings, ALUR or AEMD?

Do insiders & institutionals believe in ALUR or AEMD?

Does the media refer more to ALUR or AEMD?

Is ALUR or AEMD more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AEMD vs. The Competition

Aethlon Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools